WOUND treatment specialist firm Avita Medical has hailed the receipt of a Research & Development Tax Incentive rebate from the Australian Taxation Office worth almost $1 million.
The money delivers an "important additional resource" to help Avita commercialise its ReCell skin and wound repair platform.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Mar 17
